Collegium Pharmaceutical, Inc. (COLL)
34.80
+0.40
(+1.16%)
USD |
NASDAQ |
Jun 10, 16:00
34.80
0.00 (0.00%)
Pre-Market: 20:00
Collegium Pharmaceutical Enterprise Value : 1.616B for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.616B |
| June 09, 2026 | 1.603B |
| June 08, 2026 | 1.566B |
| June 05, 2026 | 1.570B |
| June 04, 2026 | 1.547B |
| June 03, 2026 | 1.495B |
| June 02, 2026 | 1.476B |
| June 01, 2026 | 1.518B |
| May 29, 2026 | 1.577B |
| May 28, 2026 | 1.570B |
| May 27, 2026 | 1.580B |
| May 26, 2026 | 1.583B |
| May 22, 2026 | 1.592B |
| May 21, 2026 | 1.604B |
| May 20, 2026 | 1.597B |
| May 19, 2026 | 1.578B |
| May 18, 2026 | 1.579B |
| May 15, 2026 | 1.583B |
| May 14, 2026 | 1.617B |
| May 13, 2026 | 1.618B |
| May 12, 2026 | 1.645B |
| May 11, 2026 | 1.649B |
| May 08, 2026 | 1.713B |
| May 07, 2026 | 1.763B |
| May 06, 2026 | 1.671B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.633B |
| May 04, 2026 | 1.609B |
| May 01, 2026 | 1.600B |
| April 30, 2026 | 1.581B |
| April 29, 2026 | 1.582B |
| April 28, 2026 | 1.551B |
| April 27, 2026 | 1.550B |
| April 24, 2026 | 1.541B |
| April 23, 2026 | 1.534B |
| April 22, 2026 | 1.559B |
| April 21, 2026 | 1.566B |
| April 20, 2026 | 1.600B |
| April 17, 2026 | 1.603B |
| April 16, 2026 | 1.559B |
| April 15, 2026 | 1.620B |
| April 14, 2026 | 1.643B |
| April 13, 2026 | 1.642B |
| April 10, 2026 | 1.638B |
| April 09, 2026 | 1.630B |
| April 08, 2026 | 1.571B |
| April 07, 2026 | 1.550B |
| April 06, 2026 | 1.544B |
| April 02, 2026 | 1.535B |
| April 01, 2026 | 1.566B |
| March 31, 2026 | 1.560B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Phibro Animal Health Corp. | 1.975B |
| ANI Pharmaceuticals, Inc. | 2.161B |
| Corcept Therapeutics, Inc. | 8.056B |
| Assertio Holdings, Inc. | 120.08M |
| Veru, Inc. | 19.42M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 14.50M |
| Revenue (Quarterly) | 193.52M |
| Total Expenses (Quarterly) | 179.02M |
| EPS Diluted (Quarterly) | 0.3992 |
| Gross Profit Margin (Quarterly) | 60.59% |
| Profit Margin (Quarterly) | 7.49% |
| Earnings Yield | 5.87% |
| Operating Earnings Yield | 13.94% |
| Normalized Earnings Yield | 6.853 |